Effect of the Quality of Chinese Medicinal Decoction Pieces on the Rationality of Chinese Medicinal Prescription and the Safety of Clinical Medication
(2.Department of Traditional Chinese Medicine, Rizhao City Hospital of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Rizhao, China 276800)
【Abstract】 Objective: To explore the effect of the quality of Chinese medicinal decoction pieces on the rationality of Chinese herbal prescription and the safety of clinical medication. Methods: A total of 648 patients who had to be treated with Chinese medicine decoction in The First Affiliated Hospital of Guangzhou University of Chinese Medicine from May 2016 to May 2017 were selected. During this period, the quality management of Chinese medicine decoction was implemented in our hospital. The 324 patients before the implementation of the management were taken as the control group, and 324 patients after the implementation were taken as the study group. The effect on the rationality of Chinese herbal prescription and the safety of clinical medication was analyzed. Results: The effective rate of the study group was higher than that of the control group (P < 0.05). Adverse events of prescription in the study group were fewer than those in the control group (P < 0.05). Conclusion: The quality management of Chinese medicinal decoction in Chinese pharmacies can effectively avoid adverse events and adverse drug reactions, improve the therapeutic effect of Chinese medicinal decoction in patients, and enhance the rationality and safety of Chinese medicinal prescription in Chinese pharmacies.
【Keywords】 Chinese medicinal decoction pieces; Chinese medicine pharmacy management; Rational drug use; Medication safety; Implementation effect;
(Translated by SU JB)
 Yu Q, Han LL, Zhang YE. 探讨西药临床合理用药的安全性及应对措施 [J]. Guide of China Medicine, 2017, 15 (7): 119-120 (in Chinese).
 Zhang HM, Gao SQ, Wang ZJ. Effects of Quality Control of Traditional Chinese Medicine Pharmacy on Rationality of Prescription and Safety of Clinical Drugs [J]. World Chinese Medicine, 2017, 12 (10): 2514–2517 (in Chinese).
 Zhang S, Tang D, Zang W, et al. Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma [J]. Anticancer Research, 2017, 37 (2): 465–473.
 Xu L, He RL. 加强中药饮片质量管理确保临床用药安全有效 [J]. Journal of Chinese Medicine Management, 2017, 13 (20): 77–78 (in Chinese).
 Huo LM. 处方点评对我院门诊中药饮片处方质量影响分析 [J]. Tianjin Pharmacy, 2017, 29 (3): 33–35 (in Chinese).
 Gintant G, Fermini B, Stockbridge N, et al. The Evolving Roles of Human iPSC-Derived Cardiomyocytes in Drug Safety and Discovery [J]. Cell Stem Cell, 2017, 21 (1): 14–17.
 Zhou XQ. 中药饮片处方规范性与用药合理性的现状及对策 [J]. Medical Journal of Chinese People’s Health, 2018, 30 (4): 79–80 (in Chinese).
 Lu XF. 中药饮片处方中不合理问题分析及其干预对策 [J]. Chinese Medical Journal of Metallurgical Industry, 2017, 34 (4): 468–469. (in Chinese)
 Williams SA, Murthy AC, Delisle RK, et al. Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib [J]. Circulation, 2018, 137 (10): 999–1010. (in Chinese)
 Gu XY, Liu XS, Ren Y, et al. 抗肿瘤中药饮片在调剂中发现的问题与质量监控 [J]. Health Vocational Education, 2017, 35 (18): 133–134 (in Chinese).
 LU Y, LIU J, GUO LL, et al. Investigation on the Use of TCM Decoction Pieces not in Conformity with the Chinese Pharmacopoeia and Analysis of Influential Factors in a Hospital [J]. China Pharmacy, 2017, 28 (02): 157–160 (in Chinese).
 Yang Y, Zhou X, Gao S, et al. Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China [J]. Drug Safety, 2017, 41 (5): 1–13.
 Ma SL. Analysis of the effectiveness and safety of traditional Chinese medicine prescription quality control [J]. Clinical Journal of Chinese Medicine, 2017, 9 (15): 147–148 (in Chinese).
 Jerome RN, Pulley J M, Roden DM, et al. Reply to Ward and Colleagues’ Comment on "Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors" [J]. Drug Safety, 2018, 41 (11): 1101–1101.
 Huang W, Han J, Zhang BH. Prescription review and analysis of clinical Chinese herbal medicine prescriptions in Beijing Hospital during 2015–2016 [J]. Clinical Medication Journal, 2017, 15 (07): 44–48 (in Chinese).